Chemotherapy Alone and Chemotherapy Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Pancreatic Cancer

Authors

  • Mona Salah, Sara Ahmed Ibrahim Fouda, Mostafa M. Toam, Eman S. Abdelraouf Author

DOI:

https://doi.org/10.48047/tkckpe81

Keywords:

Chemotherapy, Advanced Pancreatic Cancer, Chemoradiotherapy

Abstract

Background: Locally advanced pancreatic cancer (LAPC) remains a formidable therapeutic challenge, with most patients presenting at an unresectable stage. The optimal management strategy for LAPC continues to be debated, particularly the role of chemoradiotherapy (CRT) following induction chemotherapy.

Downloads

Download data is not yet available.

References

Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J Oncol. 2019;10(1):10-27. doi:10.14740/wjon1166

Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: Cancer today. International Agency for Research on Cancer. Published 2020. Accessed May 22, 2025. https://gco.iarc.fr/

Downloads

Published

2024-03-20

How to Cite

Chemotherapy Alone and Chemotherapy Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Pancreatic Cancer (Mona Salah, Sara Ahmed Ibrahim Fouda, Mostafa M. Toam, Eman S. Abdelraouf , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 5366-5377. https://doi.org/10.48047/tkckpe81